Fairfield, Bush & Co. Regeneron Pharmaceuticals, Inc. Transaction History

Fairfield, Bush & Co.

$168 Billion
Q3 2024

A detailed history of Fairfield, Bush & Co. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fairfield, Bush & Co. holds 1,839 shares of REGN stock, worth $1.39 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

1,839

Previous 1,976 6.93%

Holding current value

$1.39 Million

Previous $2.08 Billion 6.91%

% of portfolio

1.15%

Previous 1.24%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $140,300 - $164,641	-137 Reduced 6.93%	1,839 $1.93 Billion
Q2 2024 Aug 15, 2024	SELL	$883.2 - $1071.19 $5,299 - $6,427	-6 Reduced 0.3%	1,976 $2.08 Billion
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $68,604 - $75,494	-76 Reduced 3.69%	1,982 $1.91 Billion
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $95,347 - $108,449	123 Added 6.36%	2,058 $1.81 Billion
Q3 2023 Nov 15, 2023	BUY	$692.45 - $844.37 $79,631 - $97,102	115 Added 6.32%	1,935 $1.59 Billion
Q2 2023 Aug 15, 2023	BUY	$700.03 - $830.35 $66,502 - $78,883	95 Added 5.51%	1,820 $1.31 Billion
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $166,720 - $202,607	-245 Reduced 12.44%	1,725 $1.42 Billion
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $120,707 - $131,052	171 Added 9.51%	1,970 $1.42 Billion
Q3 2022 Nov 07, 2022	BUY	$573.97 - $724.32 $88,965 - $112,269	155 Added 9.43%	1,799 $1.24 Million
Q2 2022 Aug 09, 2022	SELL	$548.35 - $738.84 $93,219 - $125,602	-170 Reduced 9.37%	1,644 $972,000
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $379,091 - $444,899	-637 Reduced 25.99%	1,814 $1.27 Million
Q4 2021 Feb 09, 2022	SELL	$543.48 - $670.97 $27,174 - $33,548	-50 Reduced 2.0%	2,451 $1.55 Million
Q3 2021 Nov 08, 2021	SELL	$574.03 - $680.96 $140,637 - $166,835	-245 Reduced 8.92%	2,501 $1.51 Million
Q2 2021 Aug 02, 2021	BUY	$472.8 - $558.54 $610,857 - $721,633	1,292 Added 88.86%	2,746 $1.53 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $252,402 - $309,733	565 Added 63.55%	1,454 $687,000
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $237,236 - $301,558	-496 Reduced 35.81%	889 $429,000
Q3 2020 Nov 18, 2020	BUY	$544.75 - $658.21 $438,523 - $529,859	805 Added 138.79%	1,385 $775,000
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $286,125 - $373,473	580 New	580 $362,000
Q4 2017 Feb 22, 2018	SELL	$358.63 - $469.95 $179,315 - $234,975	-500 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	500	500 $246,000

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.

Account

Fairfield, Bush & Co. Regeneron Pharmaceuticals, Inc. Transaction History